- Vaccination of the patients with autoimmune inflammatory disease on treatment with new biologics and JAK inhibitors +12019 | First Faculty of Medicine
- Inhibitors of Janus kinases in the therapy of rheumatoid arthritis2019 | First Faculty of Medicine
- Janus kinase inhibitors in clinical practice: data from the ATTRA registry2020 | First Faculty of Medicine
- Clinical experience with Janus kinase inhibitors2019 | First Faculty of Medicine
- Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature2022 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- JAK-inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID and EBMT IEWP retrospective study2024 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Léčba PCSK9 inhibitory v praxPublication without faculty affiliation
- JAK inhibition in the treatment of inflammatory rheumatic diseases2023 | First Faculty of Medicine
- What we (don't) know today about proton pump inhibitors2008 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Skin toxicity of BRAF and MEK inhibitors2021 | First Faculty of Medicine
- Inhibitors of DPP-4 and cardiovascular effects2016 | Faculty of Medicine in Pilsen
- Second-generation integrase inhibitors2016 | First Faculty of Medicine
- Proton pump inhibitors in clinical practice use2010 | Faculty of Medicine in Hradec Králové
- DPP-4 inhibitors and autoimmunity2014 | Third Faculty of Medicine, First Faculty of Medicine
- Use of aromatase inhibitors to stimulate the ovaries2006 | Publication without faculty affiliation
- Plant Kunitz Protease Inhibitors: Structural and Functional Diversity2016 | Faculty of Science
- Proton pump inhibitors by children2022 | First Faculty of Medicine
- Postavení inhibitorů Janusových kináz v revmatologii2021 | First Faculty of Medicine
- Therapeutic proton pump inhibitor test2016 | Second Faculty of Medicine
- Kidney cancer. What is the next step after failure of treatment with angiogenesis inhibitors?2010 | Second Faculty of Medicine
- Inhibitors of platelet glycoprotein receptors type IIb/IIIa2003 | Second Faculty of Medicine
- Selected case reports from the tofacitinib clinical program2019 | First Faculty of Medicine
- Current and Novel Inhibitors of HIV Protease2009 | Faculty of Science, Third Faculty of Medicine
- Angiotensin-converting enzyme inhibitor-induced angioedema2019 | Second Faculty of Medicine, First Faculty of Medicine
- Tofacitinib induction efficacy and safety in ulcerative colitis at week 8 - results from clinical practice2020 | First Faculty of Medicine
- Ideal patient for IL-17 inhibitors treatment2022 | First Faculty of Medicine
- Proteasome inhibitors in the treatment of multiple myeloma2021 | Faculty of Medicine in Hradec Králové
- Janus kinase inhibitors in the treatment of rheumatoid arthritis2020 | First Faculty of Medicine
- Effect of target therapy with BRAF and MEK inhibitors on the immune system in metastatic melanoma2023 | First Faculty of Medicine